Propanc Biopharma Ord Shs
PPCB0.711USD
-0.009-1.25%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
9.47MMarket Cap
0.03P/E TTM
More Details of Company
Propanc Biopharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Propanc Biopharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
2.50M
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
2.00M
--
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
50.00K
--
Ms. Annie Vanbroekhoven
Ms. Annie Vanbroekhoven
Independent Director
Independent Director
--
--
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Ms. Jeannine Zimmerman
Ms. Jeannine Zimmerman
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
2.50M
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
2.00M
--
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
50.00K
--
Ms. Annie Vanbroekhoven
Ms. Annie Vanbroekhoven
Independent Director
Independent Director
--
--
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
--
--
Ms. Jeannine Zimmerman
Ms. Jeannine Zimmerman
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
28.43%
Kenyon (Julian Norman)
19.52%
Zelinger (Josef)
14.96%
Marex Group plc
0.53%
Himy (Joseph)
0.37%
Other
36.18%
Shareholders
Shareholders
Proportion
Nathanielsz (Sylvia)
28.43%
Kenyon (Julian Norman)
19.52%
Zelinger (Josef)
14.96%
Marex Group plc
0.53%
Himy (Joseph)
0.37%
Other
36.18%
Shareholder Types
Shareholders
Proportion
Individual Investor
63.29%
Investment Advisor
0.53%
Research Firm
0.31%
Other
35.87%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
4
112.11K
0.84%
-1.15M
2025Q3
4
112.11K
0.84%
-1.15M
2025Q2
1
900.01K
7.75%
+900.01K
2022Q4
1
--
0.00%
--
2022Q3
2
--
0.00%
--
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nathanielsz (Sylvia)
3.80M
28.43%
--
--
Sep 25, 2025
Kenyon (Julian Norman)
2.50M
19.52%
--
--
Sep 25, 2025
Zelinger (Josef)
2.00M
14.96%
--
--
Sep 25, 2025
Marex Group plc
70.43K
0.53%
+70.43K
--
Sep 30, 2025
Himy (Joseph)
50.00K
0.37%
+50.00K
--
Sep 25, 2025
Virtu Americas LLC
41.68K
0.31%
+41.68K
--
Sep 30, 2025
Morgan Stanley Smith Barney LLC
1.00
0%
+1.00
--
Sep 30, 2025
Ionic Ventures LLC
--
0%
-1.26M
-100.00%
Sep 30, 2025
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Propanc Biopharma Ord Shs?
The top five shareholders of Propanc Biopharma Ord Shs are:
Nathanielsz (Sylvia) holds 3.80M shares, accounting for 28.43% of the total shares.
Kenyon (Julian Norman) holds 2.50M shares, accounting for 19.52% of the total shares.
Zelinger (Josef) holds 2.00M shares, accounting for 14.96% of the total shares.
Marex Group plc holds 70.43K shares, accounting for 0.53% of the total shares.
Himy (Joseph) holds 50.00K shares, accounting for 0.37% of the total shares.
Nathanielsz (Sylvia) holds 3.80M shares, accounting for 28.43% of the total shares.
Kenyon (Julian Norman) holds 2.50M shares, accounting for 19.52% of the total shares.
Zelinger (Josef) holds 2.00M shares, accounting for 14.96% of the total shares.
Marex Group plc holds 70.43K shares, accounting for 0.53% of the total shares.
Himy (Joseph) holds 50.00K shares, accounting for 0.37% of the total shares.
What are the top three shareholder types of Propanc Biopharma Ord Shs?
The top three shareholder types of Propanc Biopharma Ord Shs are:
Nathanielsz (Sylvia)
Kenyon (Julian Norman)
Zelinger (Josef)
Nathanielsz (Sylvia)
Kenyon (Julian Norman)
Zelinger (Josef)
How many institutions hold shares of Propanc Biopharma Ord Shs (PPCB)?
As of 2025Q4, 4 institutions hold shares of Propanc Biopharma Ord Shs, with a combined market value of approximately 112.11K, accounting for 0.84% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Propanc Biopharma Ord Shs?
In --, the -- business generated the highest revenue for Propanc Biopharma Ord Shs, amounting to -- and accounting for --% of total revenue.
